Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK)
HKD 2.51
(-0.79%)
HKD 2.51
(-0.79%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 71.01 Million | 165.26 Million | 268.89 Million | 113 Million | 269.23 Million | 173.93 Million |
| Net Income | 108.44 Million | 137.27 Million | 212.38 Million | 164.25 Million | 220.65 Million | 143.07 Million |
| Depreciation & Amortization | 59.92 Million | 80.97 Million | 60.85 Million | 53.61 Million | 56.67 Million | 53.21 Million |
| Deferred income taxes | - | - | -22.68 Million | - | - | - |
| Stock-based compensation | -1.84 Million | 7.68 Million | 64.97 Million | - | - | - |
| Change in working capital | -137.96 Million | -60.28 Million | -48.63 Million | -103.8 Million | -17.24 Million | -19.31 Million |
| Other non-cash items | 4.97 Million | -376.32 Thousand | 2.01 Million | -1.06 Million | 9.15 Million | -3.03 Million |
| Investing Cash Flow | -45.37 Million | -96.74 Million | -355.67 Million | -46.53 Million | -21.14 Million | -48.63 Million |
| Investments in PPE | -98.96 Million | -87.3 Million | -120.11 Million | -42.41 Million | -40.38 Million | -37.78 Million |
| Acquisitions | - | - | -259.61 Million | -36 Million | 6.79 Million | -24 Million |
| Investment purchases | -3.9 Billion | -4.02 Billion | - | -3.08 Billion | -1.66 Billion | -1.86 Billion |
| Sales/Maturities of investments | 3.96 Billion | 4.01 Billion | - | 3.1 Billion | 1.66 Billion | 1.88 Billion |
| Other Investing Activities | 53.59 Million | -9.44 Million | 24.06 Million | 12.02 Million | 2.61 Million | 1.09 Million |
| Financing Cash Flow | -118.97 Million | 11.6 Million | -101.16 Million | 753.84 Million | -259.56 Million | -5.39 Million |
| Debt repayment | -100 Million | -9.51 Million | -7.5 Million | -200 Million | -150 Million | -140 Million |
| Dividends payments | -76.15 Million | -71.03 Million | -52.15 Million | -69.76 Million | -70.19 Million | -27.69 Million |
| Common Stock Repurchased | - | -8.69 Million | -40.82 Million | -945.13 Million | - | - |
| Common Stock Issuance | - | 18.21 Million | 48.32 Million | 996.19 Million | - | - |
| Other Financing Activities | 66.54 Million | 82.64 Million | -49.01 Million | 972.55 Million | -39.37 Million | 162.29 Million |
| Accounts receivables | -10.47 Million | -89.72 Million | -95.37 Million | -83.53 Million | -122.9 Million | -206.1 Million |
| Accounts payables | - | 89.72 Million | 95.37 Million | 83.53 Million | 122.9 Million | - |
| Inventory | -6.57 Million | -5.84 Million | 318.19 Thousand | -5.41 Million | -4.32 Million | 6.97 Million |
| Other working capital | -120.91 Million | -54.44 Million | -48.95 Million | -98.38 Million | -12.92 Million | -26.28 Million |
| Cash at beginning of period | 1.28 Billion | 1.2 Billion | 1.39 Billion | 576.79 Million | 588.22 Million | 468.14 Million |
| Cash at end of period | 1.19 Billion | 1.28 Billion | 1.2 Billion | 1.39 Billion | 576.79 Million | 588.22 Million |
| Capital Expenditure | -98.96 Million | -87.3 Million | -120.11 Million | -42.41 Million | -40.38 Million | -37.78 Million |
| Effect of forex changes on cash | -68.23 Thousand | 292.77 Thousand | -74.18 Thousand | -224.43 Thousand | 56.18 Thousand | 164 Thousand |
| Net cash flow / Change in cash | -93.4 Million | 80.42 Million | -188 Million | 820.09 Million | -11.42 Million | 120.07 Million |
| Free Cash Flow | -27.95 Million | 77.96 Million | 148.78 Million | 70.59 Million | 228.84 Million | 136.15 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | 2.34 Million | 108.44 Million | 18.73 Million | 21.45 Million | 59.65 Million |
| Depreciation & Amortization | - | - | 59.92 Million | 53.72 Million | -28.48 Million | 28.48 Million |
| Deferred income taxes | - | - | - | - | -137.25 Million | 137.25 Million |
| Stock-based compensation | - | - | -1.84 Million | -1.84 Million | 1.84 Million | -1.84 Million |
| Change in working capital | - | - | -137.96 Million | -17.04 Million | 135.41 Million | -135.41 Million |
| Other non-cash items | - | 41.59 Million | 4.97 Million | 15.73 Million | 117.49 Million | 100.63 Million |
| Investing Cash Flow | 8.13 Million | -3.8 Million | -45.37 Million | -9.88 Million | -26.78 Million | 227.02 Million |
| Investments in PPE | 2.24 Million | -10.53 Million | -98.96 Million | -13.32 Million | -31.52 Million | -2.86 Million |
| Acquisitions | -917.55 Million | 919.29 Million | - | - | - | - |
| Investment purchases | - | - | -3.9 Billion | - | - | - |
| Sales/Maturities of investments | - | - | 3.96 Billion | - | - | - |
| Other Investing Activities | 923.44 Million | -913 Million | 53.59 Million | 3.44 Million | 4.74 Million | 229.89 Million |
| Financing Cash Flow | -2.85 Million | -2.66 Million | -118.97 Million | -105.8 Million | -72.32 Million | 64.4 Million |
| Debt repayment | - | -2.66 Million | -100 Million | - | - | -70.09 Million |
| Dividends payments | - | - | -76.15 Million | -1.53 Million | -71.9 Million | -689.99 Thousand |
| Common Stock Repurchased | - | - | - | - | -1.00 | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -2.85 Million | -2.66 Million | 66.54 Million | 5.1 Million | -418.11 Thousand | 65.09 Million |
| Accounts receivables | - | - | -10.47 Million | -10.47 Million | 125.11 Million | -125.11 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | -6.57 Million | -6.57 Million | 10.29 Million | -10.29 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 1.23 Billion | 1.19 Billion | 1.28 Billion | 1.24 Billion | 1.23 Billion | 888 Million |
| Cash at end of period | 1.22 Billion | 1.23 Billion | 1.19 Billion | 1.19 Billion | 1.24 Billion | 1.23 Billion |
| Capital Expenditure | 2.24 Million | -10.53 Million | -98.96 Million | -13.32 Million | -31.52 Million | -2.86 Million |
| Effect of forex changes on cash | 94.91 Thousand | 36.71 Thousand | -68.23 Thousand | -175.32 Thousand | -22.88 Thousand | 176.19 Thousand |
| Net cash flow / Change in cash | -10.91 Million | 37.49 Million | -93.4 Million | -46.56 Million | 11.33 Million | 343.11 Million |
| Free Cash Flow | 2.24 Million | 33.4 Million | -27.95 Million | 55.97 Million | 78.93 Million | 48.64 Million |
BKM
6757
AC
FNBKY
AUKNY
THS